![Craig Millian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Millian
Verkställande Direktör på
HLS THERAPEUTICS INC.
Förmögenhet: 49 980 $ per 2026-09-30
Profil
Craig Millian is currently Chief Executive Officer & Director at HLS Therapeutics, Inc. since 2023.
Former roles include Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023, Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018, Vice President-Commercial at Vertex Pharmaceuticals, Inc., and a position at EMD Serono, Inc. from 2012 to 2018.
Education includes an undergraduate degree from the University of Pennsylvania and an MBA from New York University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,05 % | 2026-08-20 | 17 000 ( 0,05 % ) | 49 980 $ | 2026-09-30 |
Aktiva positioner av Craig Millian
| Företag | Position | Start |
|---|---|---|
| HLS THERAPEUTICS INC. | Verkställande Direktör | 2023-05-01 |
Tidigare kända positioner av Craig Millian
| Företag | Position | Slut |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Verksamhetschef | 2023-04-14 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Företagsledare/Principal | 2018-12-01 |
| VERTEX PHARMACEUTICALS INCORPORATED | Företagsledare/Principal | - |
Craig Millians utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
